Antimicrobial Susceptibility Panel, Yeast, Varies
Use
This test is used to determine in vitro quantitative antifungal susceptibility (minimum inhibitory concentration) of non-fastidious yeast. It aids in the management of patients with refractory oropharyngeal infections due to Candida species, especially when patients appear to be failing standard therapeutic agents. It is also crucial in cases of invasive infections caused by Candida species, where the use of azole antifungal agents might be uncertain, particularly when the infection is due to non-Candida albicans organisms.
Special Instructions
When ordering this test, be aware that the susceptibility yeast panel will be performed at an additional charge. It is important to submit pure cultures as mixed cultures are not accepted. The clinical report will follow the Clinical Laboratory Standards Institute guidelines, and results are reported in micrograms per milliliter.
Limitations
This assay is not suitable for determining the minimum inhibitory concentration for dimorphic yeast or filamentous fungi. It requires organisms to be in pure culture and actively growing. The test results may be influenced by improper specimen collection, handling, or inappropriate test selection.
New York Approved
Methodology
Culture-based
Biomarkers
LOINC Codes
- 29577-4
- 29577-4
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Infecting yeast isolate
Minimum Volume
Not provided
Container
Sabouraud's dextrose agar slant
Collection Instructions
Organism must be in pure culture, actively growing. Do not submit mixed cultures.
Causes for Rejection
Agar plate
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Ambient (preferred) |